BCAX Annual EBITDA
-$51.96 M
-$14.24 M-37.75%
01 December 2023
Summary:
As of January 20, 2025, BCAX annual earnings before interest, taxes, depreciation & amortization is -$51.96 million, with the most recent change of -$14.24 million (-37.75%) on December 1, 2023. During the last 3 years, it has fallen by -$14.24 million (-37.75%). BCAX annual EBITDA is now -37.75% below its all-time high of -$37.72 million, reached on December 1, 2022.BCAX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCAX Quarterly EBITDA
-$20.61 M
0.00%
30 September 2024
Summary:
As of January 20, 2025, BCAX quarterly earnings before interest, taxes, depreciation & amortization is -$20.61 millionOver the past year, it has dropped by -$11.09 million (-116.34%). BCAX quarterly EBITDA is now -116.34% below its all-time high of -$9.53 million, reached on September 30, 2023.BCAX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCAX TTM EBITDA
-$20.61 M
0.00%
30 September 2024
Summary:
As of January 20, 2025, BCAX TTM earnings before interest, taxes, depreciation & amortization is -$20.61 millionOver the past year, it has dropped by -$11.09 million (-116.34%). BCAX TTM EBITDA is now -116.34% below its all-time high of -$9.53 million, reached on September 30, 2023.BCAX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCAX EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -37.8% | -116.3% | -116.3% |
| 3 y3 years | -37.8% | -116.3% | -116.3% |
| 5 y5 years | -37.8% | -116.3% | -116.3% |
BCAX EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -37.8% | at low | -116.3% | at low | -116.3% | at low |
| 5 y | 5-year | -37.8% | at low | -116.3% | at low | -116.3% | at low |
| alltime | all time | -37.8% | at low | -116.3% | at low | -116.3% | at low |
Bicara Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$20.61 M(+116.3%) | -$20.61 M(+116.3%) |
| Dec 2023 | -$51.96 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$9.53 M | -$9.53 M |
| Dec 2022 | -$37.72 M | - | - |
FAQ
- What is Bicara Therapeutics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Bicara Therapeutics?
- What is Bicara Therapeutics annual EBITDA year-on-year change?
- What is Bicara Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Bicara Therapeutics?
- What is Bicara Therapeutics quarterly EBITDA year-on-year change?
- What is Bicara Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Bicara Therapeutics?
- What is Bicara Therapeutics TTM EBITDA year-on-year change?
What is Bicara Therapeutics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of BCAX is -$51.96 M
What is the all time high annual EBITDA for Bicara Therapeutics?
Bicara Therapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is -$37.72 M
What is Bicara Therapeutics annual EBITDA year-on-year change?
Over the past year, BCAX annual earnings before interest, taxes, depreciation & amortization has changed by -$14.24 M (-37.75%)
What is Bicara Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of BCAX is -$20.61 M
What is the all time high quarterly EBITDA for Bicara Therapeutics?
Bicara Therapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$9.53 M
What is Bicara Therapeutics quarterly EBITDA year-on-year change?
Over the past year, BCAX quarterly earnings before interest, taxes, depreciation & amortization has changed by -$11.09 M (-116.34%)
What is Bicara Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of BCAX is -$20.61 M
What is the all time high TTM EBITDA for Bicara Therapeutics?
Bicara Therapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$9.53 M
What is Bicara Therapeutics TTM EBITDA year-on-year change?
Over the past year, BCAX TTM earnings before interest, taxes, depreciation & amortization has changed by -$11.09 M (-116.34%)